Biological and structural analysis of truncated analogs of PACAP27

Journal of Molecular Neuroscience

Volumn 36, Issue 1-3, 2008, Pages 260-269

  Bourgault, Steve ^a,b,c   Vaudry, David ^b,c   Guilhaudis, Laure ^b   Raoult, Émilie ^b,c   Couvineau, Alain ^d   Laburthe, Marc ^d   Ségalas Milazzo, Isabelle ^b   Vaudry, Hubert ^b,c   Fournier, Alain ^a,c  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b UNIVERSITÉ DE ROUEN   (France)

^c International Associated Laboratory Samuel de Champlain   (France)

^d CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

Author keywords

Fragments; PAC1 receptor; PACAP; PC12 cells; Helical content

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR 1;

ALPHA HELIX; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CALCIUM MOBILIZATION; CELL PROLIFERATION; CIRCULAR DICHROISM; CONTROLLED STUDY; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; RAT; STRUCTURE ANALYSIS;

EID: 58149098527     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-008-9081-7     Document Type: Article

References (32)

1. M. A. Andrade P. Chacón J. J. Merelo F. Morán 1993 Evaluation of secondary structure of proteins from UV circular dichroism using an unsupervised learning neural network Protein Engineering 6 383 390
2. A. Arimura M. Li V. Batuman 2006 Treatment of renal failure associated with multiple myeloma and other diseases by PACAP-38 Annals of the New York Academy of Sciences 1070 1 4
3. Bourgault, S., Vaudry, D., Botia, B., et al. (2008). Novel stable PACAP analogs with potent activity towards the PAC1 receptor. Peptides, DOI 10.1016/j.peptides.2008.01.022.
4. W. H. Chen S. F. Tzeng 2005 Pituitary adenylate cyclase-activating polypeptide prevents cell death in the spinal cord with traumatic injury Neuroscience Letters 384 117 121
5. Y. Chen B. Samal C. R. Hamelink 2006 Neuroprotection by endogenous and exogenous PACAP following stroke Regulatory Peptides 137 4 19
6. A. Dejda P. Sokolowska J. Z. Nowak 2005 Neuroprotective potential of three neuropeptides PACAP, VIP and PHI Pharmacological Reports 57 307 320
7. M. A. Forget N. Lebel P. Sirois Y. Boulanger A. Fournier 1996 Biological and molecular analyses of structurally reduced analogues of endothelin-1 Molecular Pharmacology 49 1071 1079
8. A. Fournier D. Gagnon R. Quirion 1994 Conformational and biological studies of neuropeptide Y analogs containing structural alterations Molecular Pharmacology 45 93 101
9. R. González-Muñiz M. Martín-Martínez C. Granata 2001 Conformationally restricted PACAP27 analogues incorporating type II/II¢ IBTM beta-turn mimetics. Synthesis, NMR structure determination, and binding affinity Bioorganic & Medicinal Chemistry 9 3173 3183
10. P. Gourlet A. Vandermeers M. C. Vandermeers-Piret J. Rathe P. De Neef P. Robberecht 1996 C-terminally shortened pituitary adenylate cyclase-activating peptides (PACAP) discriminate PACAP I, PACAP II-VIP1 and PACAP II-VIP2 recombinant receptors Regulatory Peptides 62 125 130
11. H. Inooka S. Endo C. Kitada E. Mizuta M. Fujino 1992 Pituitary adenylate cyclase activating polypeptide (PACAP) with 27 residues. Conformation determined by 1H NMR and CD spectroscopies and distance geometry in 25% methanol solution International Journal of Peptide & Protein Research 40 456 464
12. H. Inooka T. Ohtaki O. Kitahara 2001 Conformation of a peptide ligand bound to its G-protein coupled receptor Nature Structural Biology 8 161 165
13. L. Y. Kong J. L. Maderdrut G. H. Jeohn J. S. Hong 1999 Reduction of lipopolysaccharide-induced neurotoxicity in mixed cortical neuron/glia cultures by femtomolar concentrations of pituitary adenylate cyclase-activating polypeptide Neuroscience 91 493 500
14. C. Martinez C. Abad M. Delgado 2002 Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor Proceedings of the National Academy of Sciences of the United States of America 99 1053 1058
15. P. Nicole L. Lins C. Rouyer-Fessard 2000 Identification of key residues for interaction of vasoactive intestinal peptide with human VPAC1 and VPAC2 receptors and development of a highly selective VPAC1 receptor agonist. Alanine scanning and molecular modeling of the peptide Journal of Biological Chemistry 275 24003 24012
16. G. L. Olson D. R. Bolin M. P. Bonner 1993 Concepts and progress in the development of peptide mimetics Journal of Medicinal Chemistry 36 3039 3049
17. S. Onoue K. Endo K. Ohshima T. Yajima K. Kashimoto 2002 The neuropeptide PACAP attenuates beta-amyloid (1-42)-induced toxicity in PC12 cells Peptides 23 1471 1478
18. D. Reglodi A. Lubics P. Kiss 2006 Effect of PACAP in 6-OHDA-induced injury of the substantia nigra in intact young and ovariectomized female rats Neuropeptides 40 265 274
19. P. Robberecht P. Gourlet P. De Neef 1992 Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist European Journal of Biochemistry 207 239 246
20. J. M. Scholtz H. Qian E. J. York J. M. Stewart R. L. Baldwin 1991 Parameters of helix-coil transition theory for alanine-based peptides of varying chain lengths in water Biopolymers 31 1463 1470
21. N. Shintani S. Suetake H. Hashimoto 2005 Neuroprotective action of endogenous PACAP in cultured rat cortical neurons Regulatory Peptides 126 123 128
22. N. Sreerema S. Y. Venyaminov R. W. Woody 1999 Estimation of the number of helical and strand segments in proteins using CD spectroscopy Protein Science 8 370 380
23. C. Sun D. Song R. A. Davis-Taber 2007 Solution structure and mutational analysis of pituitary adenylate cyclase-activating polypeptide binding to the extracellular domain of PAC1-RS Proceedings of the National Academy of Sciences of the United States of America 104 7875 7880
24. I. H. M. Van Stokkum H. J. W. Spoelder M. Bloemendal R. Van Grondelle F. C. A. Groen 1990 Estimation of protein secondary structure and error analysis from CD spectra Analytical Biochemistry 191 110 118
25. A. Vandermeers S. Vandenborre X. Hou 1992 Antagonistic properties are shifted back to agonistic properties by further N-terminal shortening of pituitary adenylate-cyclase-activating peptides in human neuroblastoma NB-OK-1 cell membranes European Journal of Biochemistry 208 815 819
26. D. Vaudry B. J. Gonzalez M. Basille L. Yon A. Fournier H. Vaudry 2000 Pituitary adenylate cyclase-activating polypeptide and its receptors: From structure to functions Pharmacological Reviews 52 269 324
27. D. Vaudry C. Hamelink R. Damadzic R. L. Eskay B. Gonzalez L. E. Eiden 2005 Endogenous PACAP acts as a stress response peptide to protect cerebellar neurons from ethanol or oxidative insult Peptides 26 2518 2524
28. D. Vaudry T. F. Pamantung M. Basille 2002 PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis European Journal of Neuroscience 15 1451 1460
29. D. Vaudry C. Rousselle M. Basille 2002 Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death Proceedings of the National Academy of Sciences of the United States of America 99 6398 6403
30. L. Whitmore B. A. Wallace 2004 DICHROWEB: An online server for protein secondary structure analyses from circular dichroism spectroscopic data Nucleic Acids Research 32 668 673
31. V. Wray C. Kakoschke K. Nokihara S. Naruse 1993 Solution structure of pituitary adenylate cyclase activating polypeptide by nuclear magnetic resonance spectroscopy Biochemistry 32 5832 5841
32. K. Yamamoto H. Hashimoto S. Tomimoto 2003 Overexpression of PACAP in transgenic mouse pancreatic beta-cells enhances insulin secretion and ameliorates streptozotocin-induced diabetes Diabetes 52 1155 1162